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Abstract
Background: Early identification of patients at risk of developing acute lung injury (ALI) is critical for potential
preventive strategies. We aimed to derive and validate an acute lung injury prediction score (EDLIPS) in a
multicenter sample of emergency department (ED) patients.
Methods: We performed a subgroup analysis of 4,361 ED patients enrolled in the previously reported multicenter
observational study. ED risk factors and conditions associated with subsequent ALI development were identified
and included in the EDLIPS model. Scores were derived and validated using logistic regression analyses. The model
was assessed with the area under the receiver-operating curve (AUC) and compared to the original LIPS model
(derived from a population of elective high-risk surgical and ED patients) and the Acute Physiology and Chronic
Health Evaluation (APACHE II) score.
Results: The incidence of ALI was 7.0% (303/4361). EDLIPS discriminated patients who developed ALI from
those who did not with an AUC of 0.78 (95% CI 0.75, 0.82), better than the APACHE II AUC 0.70 (p≤0.001) and
similar to the original LIPS score AUC 0.80 (p=0.07). At an EDLIPS cutoff of 5 (range −0.5, 15) positive and
negative likelihood ratios (95% CI) for ALI development were 2.74 (2.43, 3.07) and 0.39 (0.30, 0.49), respectively,
with a sensitivity 0.72(0.64, 0.78), specificity 0.74 (0.72, 0.76), and positive and negative predictive value of 0.18
(0.15, 0.21) and 0.97 (0.96, 0.98).
Conclusion: EDLIPS may help identify patients at risk for ALI development early in the course of their ED
presentation. This novel model may detect at-risk patients for treatment optimization and identify potential
patients for ALI prevention trials.
Background
Acute lung injury (ALI) is widely recognized as an im-
portant cause of poor outcome in critically ill patients.
Acute respiratory distress syndrome (ARDS), a severe
variant of ALI, was originally described in 1967 by
Ashbaugh et al. as the acute onset of tachypnea, hypox-
emia, and poor pulmonary compliance resistant to
traditional medical therapies. At the time, the authors
suggested that the use of positive end expiratory pres-
sure and corticosteroids may be of utility [1]. This
prompted investigations and dialogue of an international
scale that established standardized parameters used to
describe ALI, the 1994 American European Consensus
Conference criteria: acute hypoxemia with a ratio of the
partial pressure of arterial oxygen to the fraction of
inspired oxygen (PaO2:FiO2) of 300 mmHg or less
(ARDS is defined as PaO2:FiO2 200 mmHg or less), bi-
lateral infiltrates seen on a frontal chest radiograph that
are consistent with pulmonary edema, and no clinical
evidence of left atrial hypertension [2].
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intensive care unit (ICU)condition; a complication of
protracted illness during an inpatient stay, infrequently
diagnosed in the emergency department (ED) [3]. Nu-
merous reports, however, have revealed that ALI devel-
opment is often early, with 50% of cases occurring
within the first 24 h of admission [4]. Among ED popu-
lations, it has been documented to develop within hours
of initial presentation [5-7]. Most commonly, patients
are resuscitated for respiratory distress and subsequently
experience a precipitous decline in clinical status prompt-
ing intubation, mechanical ventilation, the use of increas-
ing doses of supplemental oxygen, and positive end
expiratory pressure (PEEP). Because of similarities in
presentation, these ALI cases may have been difficult to
diagnose and were managed as cardiogenic pulmonary
edema [5].
The source of the initiating insult in ALI may be pul-
monary (i.e., aspiration, pneumonia) or extrapulmonary
(sepsis, shock, pancreatitis) in origin. The pathophysi-
ology involves the disruption of the alveolar capillary
interface, resulting in the extravasation of protein-rich
fluid into alveoli, the induction of local inflammatory
mediators, and hypercoagulability [8-10]. The clinical
picture is characterized by profound hypoxemia, ventila-
tion perfusion mismatch, and restrictive lung disease
[11]. The outcome is frequently prolonged mechanical
ventilation and ICU length of stay, and ultimately death.
Even previously healthy survivors have long-term phys-
ical and cognitive impairment [12].
As of the date of this publication, a PubMed database
search of the literature yields over 25,000 articles pub-
lished since 1967 with keywords acute lung injury or
acute respiratory distress syndrome. Despite countless
large-scale investigations, ALI and ARDS affect well over
200,000 persons in the US annually, few beneficial treat-
ments have emerged, and the mortality rate is 38-44%
[13,14].
To date, supportive care with the use of a low tidal
volume ventilation strategy remains the sole effective
therapeutic measure for ALI [15]. Recognizing the pau-
city of therapies, investigators have posited whether a
role for preventive strategies may exist to curb the pro-
gression to ALI in the at-risk patient.
Previous research of ALI has largely been limited to
ICU populations; hence, recruitment into study proto-
cols often occurs well after the diagnosis of ALI has
been established [3,16]. This approach likely identifies
patients that are beyond the pre-morbid window of
intervention. The presentation of known predispositions
to ALI such as pneumonia, sepsis, shock, and trauma to
emergency rooms may provide opportunities to limit a
patient’s risk of developing downstream direct and indir-
ect pulmonary insults. Hence, reliable identification and
risk stratification of ED patients for ALI may prove a vi-
able approach for early goal-directed interventions and
preventive measures.
While the pathophysiology of ALI is well documented,
models predicting the risk for developing ALI are not
well established. While scores have been developed from
mixed populations, none has been derived and validated
in an exclusively emergency department population [17].
The purpose of this study is to develop a model using
readily accessible clinical data for the identification of ED
patients at risk for ALI. Using a previously published pre-
diction model for ALI, the Lung Injury Prediction Score
(LIPS), we perform a multi-center derivation, model re-
finement (EDLIPS), and validation study of emergency
department patients presenting with predisposing risk
factors of ALI previously identified in the literature [17].
Methods
Study design
This is a subgroup analysis of data from a multicenter,
observational cohort study, the United States Critical In-
jury and Illness Trial Group - Lung Injury Prevention
Study 1 (USCIITG-LIPS 1). Each participating center
sought approval from its local institutional review board.
Study setting
From March through August 2009, 22 centers (20
American and 2 Turkish hospitals) enrolled patients
with at least one ALI predisposition admitted from the
ED. Patients were enrolled prospectively at 19 study sites
and retrospectively at 3 sites.
Selection of participants
Consecutive adult ED patients admitted to academic and
community acute care hospitals were eligible for the
study if they presented with one or more study defined
ALI predisposing conditions. Patients were excluded if
they presented with ALI at initial assessment, transferred
from an in-patient setting, died in the ED, were admitted
for comfort or hospice care, or were re-admitted during
the study period. Hospital admission logs were reviewed
to minimize the possibility that patients with predispos-
ing condition were missed. After identification of at-risk
ED patients, they were followed through their hospitali-
zations prospectively in 19 hospitals. In three hospitals
that enrolled retrospectively, investigators followed the
same protocol and definitions, but data were collected
after patient discharge.
Data collection and processing
To derive and validate the proposed EDLIPS prediction
model, a subgroup analysis of a larger prospective co-
hort study was performed [17]. Baseline characteristics
including demographics, co-morbidities, and clinical
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evaluation. We used clinical variables previously docu-
mented in the literature associated with the development
of ALI [3,18-21]. Each patient was screened for 24 pre-
disposing conditions and ALI risk modifiers. Predispos-
ing conditions included shock, aspiration, sepsis,
pneumonia, acute abdomen, high-risk trauma (traumatic
brain injury, smoke inhalation, near drowning, lung con-
tusion, multiple fractures), and necessity for emergency
and high-risk surgeries (thoracic, spine, abdominal, car-
diac, aortic vascular). ALI risk modifiers included alcohol
abuse, obesity, chemotherapy, diabetes mellitus, smok-
ing, tachypnea, hypoxemia, oxygen supplementation,
hypoalbuminemia, and acidosis. During data collection, a
specific definition of each clinical variable was explicitly
outlined. The study outcome used to derive the predic-
tion rule was the diagnosis of ALI.
De-identified subject information was entered at each
center into the secure, password-protected NIH-sup-
ported web form (REDCap http://www.project-redcap.
org). Electronic range checks and validation rules were
utilized to eliminate erroneous data entry and artifacts
in numeric values. Prior to study initiation at each site,
investigators and study coordinators reviewed structured
online training (http://depts.washington.edu/kclip/about.
shtml) for ALI assessment and for definitions of each
risk factor (see Appendix 1). In addition, a formal train-
ing session was provided during the 2009 USCIITG
meeting in Nashville, TN. The principal investigators
from each site provided a written statement stating their
responsibility for the quality control of data collection
and entry.
Data analysis
All clinical variables were collected for each patient. The
criterion for diagnosis of ALI was derived from the
American-European Consensus Conference definition:
bilateral pulmonary infiltrates and hypoxemia (ALI:
PaO2/FIO2<300; ARDS: PaO2/ FIO2<200) in the ab-
sence of clinical signs of left atrial hypertension as the
main explanation for pulmonary edema.
The primary analysis consisted of a validation of the
predictive ability of the EDLIPS model, modified from
the previously validated LIPS model derived in a diverse
multi-disciplinary cohort [17]. All emergency depart-
ment patients were included in the sub-cohort analyses.
Any missing data were treated as an absent disease state
or a normal variable. To simplify the calculation, vari-
ables with minimal or no effect size were removed (i.e.,
pancreatitis, alcohol abuse, smoking, and tachypnea).
Figure 1 Study schematic.
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Total Derivation Validation
Variable* (n=4,361) (n=2,000) (n=2,361) p-value
Demographics
Median age 56.0 (41.0, 71.0) 56.0 (42.0, 71.0) 56.0 (41.0, 71.0) 0.596
Male, no. (%) 2,422 (55.5%) 1,104 (55.2%) 1,318 (55.8%) 0.680
Caucasian, no. (%), n=4,220 2,608 (61.8%) 1,193 (61.6%) 1,415 (62.0%) 0.765
Admission source, no. (%) n=4,311 0.131
Home 3,331 (77.3%) 1,557 (78.8%) 1,774 (76.0%)
Nursing facility 338 (7.8%) 151 (7.6%) 187 (8.0%)
Outside ED 440 (10.2%) 183 (9.3%) 257 (11.0%)
Other 202 (4.7%) 85 (4.3%) 117 (5.0%)
APACHE II 10.0 (6.0, 15.0) 10.0 (6.0, 15.0) 10.0 (5.0, 15.0) 0.770
Predisposing conditions
Shock 395 (9.1%) 180 (9.0%) 215 (9.1%) 0.903
Aspiration 210 (4.8%) 92 (4.6%) 118 (5.0%) 0.541
Sepsis 1,806 (41.4%) 856 (72.8%) 950 (70.2%) 0.087
Pancreatitis 323 (7.4%) 140 (7.0%) 183 (7.8%) 0.345
Pneumonia 1,227 (28.1%) 568 (28.4%) 659 (27.9%) 0.721
High-risk trauma
Traumatic brain injury 490 (11.2%) 214 (10.7%) 276 (11.7%) 0.302
Smoke inhalation 27 (0.6%) 10 (0.5%) 17 (0.7%) 0.356
Near drowning 3 (0.1%) 2 (0.1%) 1 (0.0%) 0.597
Lung contusion 188 (4.3%) 87 (4.4%) 101 (4.3%) 0.907
Multiple fractures 330 (7.6%) 141 (7.1%) 189 (8.0%) 0.235
High-risk surgery
Thoracic (noncardiac) 5 (0.1%) 3 (0.2%) 2 (0.2%) 0.526
Orthopedic spine 17 (0.4%) 6 (0.3%) 11 (0.5%) 0.381
Acute abdomen 295 (6.8%) 133 (6.7%) 162 (6.9%) 0.782
Cardiac surgery 20 (0.5%) 6 (0.3%) 14 (0.6%) 0.154
Aortic vascular 14 (0.3%) 5 (0.3%) 9 (0.4%) 0.445
Risk modifiers
Alcohol abuse 421 (9.7%) 191 (9.6%) 230 (9.7%) 0.831
Obesity 1,020 (29.1%) 456 (28.5%) 564 (29.6%) 0.451
Chemotherapy 158 (3.6%) 82 (4.1%) 76 (3.2%) 0.121
Diabetes mellitus 1,042 (23.9%) 485 (24.3%) 557 (23.6%) 0.612
Smoking (n=4019) 0.892
None 2,060 (51.3%) 932 (50.9%) 1,128 (51.6%)
Former 888 (22.1%) 408 (22.3%) 480 (22.0%)
Active 1,071 (26.7%) 493 (26.9%) 578 (26.4%)
Emergency surgery 339 (7.7%) 154 (7.7%) 185 (7.8%) 0.868
RR 20.0 (18.0, 24.0) 20.0 (18.0, 24.0) 20.0 (18.0, 24.0) 0.658
Tachypnea 315 (7.6%) 145 (7.6%) 170 (7.6%) 0.948
SpO2 95.6 (95.4, 95.7) 95.2 (95.2, 95.7) 95.7 (95.5, 95.9) 0.068
SpO2>95% 2,662 (62.3%) 1,203 (61.4%) 1,459 (63.1%) 0.254
FiO2 0.2 (0.2, 0.3) 0.2 (0.2, 0.3) 0.2 (0.2, 0.3) 0.561
Elie-Turenne et al. International Journal of Emergency Medicine 2012, 5:33 Page 4 of 11
http://www.intjem.com/content/5/1/33Variables identified to be present in fewer than ten
patients were also removed (i.e., near drowning, thoracic
surgery).
EDLIPS weighting points were adjusted based on lo-
gistic regression analysis results from a training data set
(a random sample of 2,000 patients from the cohort). If
statistically significant (p<0.05), the EDLIPS point value
was derived by doubling the parameter estimate and
rounding to the closest 0.5. The variables with less
robust p-values (p>0.05) had parameter estimates
rounded to the closest 0.5. Subsequently, the model was
independently validated in the remaining patients (valid-
ation cohort of 2,361). Model discrimination was
assessed by calculating the area under the receiver oper-
ating characteristic curve (AUC). The threshold score
providing the best combination of sensitivity and specifi-
city was determined by AUC analysis. Corresponding
positive and negative predictive values, positive and
negative likelihood ratios, and their 95% CIs were calcu-
lated. A sensitivity analysis was performed to determine
the model performance at different cutoff points.
In secondary analyses, to determine the mortality bur-
den due to the development of ALI, we performed a lo-
gistic regression analysis adjusted for ALI development,
EDLIPS, and baseline severity of illness (Acute Physi-
ology and Chronic Health Evaluation [APACHE] II
score). In addition, we compared the performance of
EDLIPS to the original LIPS previously described in the
literature [17]. All statistical analysis was operated in
SAS 9.2 (SAS Institute, Cary, NC).
Results
Characteristic of study subjects
Twenty-two centers screened 5,992 adult patients, of
whom 4,361 were admitted from the emergency depart-
ment and had at least one ALI risk factor. One hundred
sixty-six patients were excluded with ALI on presenta-
tion, ED death, or other criteria. Predisposing conditions
(aspiration, pneumonia, sepsis, shock, high-risk and
emergency surgery, and high-risk trauma: lung contu-
sion, multiple rib fractures, traumatic brain injury,
smoke inhalation, and near-drowning) and clinical and
physiological risk factors associated with ALI develop-
ment were identified (Figure 1).
The overall incidence of ALI in the ED subgroup was
7.0% (303/4,361). The incidence of ALI in the derivation
Table 2 EDLIPS points derived and assigned by weight
Predispositions Estimate 95% CI p-value EDLIPS Points
Male gender 0.512 0.089 0.935 0.018 1
Aspiration 0.900 0.204 1.595 0.011 2
Pneumonia 0.550 0.052 1.047 0.030 1
Sepsis 0.500 0.031 0.969 0.037 1
Shock 0.959 0.406 1.512 0.001 2
Lung contusion 0.823 −0.032 1.679 0.059 1
Smoke inhalation 1.505 −0.100 3.109 0.066 1.5
Long bone fractures 1.122 0.341 1.904 0.005 2
Brain injury 1.103 0.426 1.780 0.001 2
Cardiac surgery 2.584 0.619 4.549 0.010 5
Aortic surgery 2.619 0.190 5.049 0.035 5
Spine surgery 2.727 0.623 4.832 0.011 5
Acute abdomen 1.272 0.506 2.038 0.001 2.5
Risk modifiers
Diabetes mellitus −0.381 −0.896 0.133 0.146 −0.5
Cirrhosis 0.928 −0.078 1.934 0.071 1
Chemotherapy 1.181 0.405 1.957 0.003 2
Obesity (BMI >30) 0.795 0.352 1.237 0.000 1.5
Acidosis (pH <7.35) 0.852 0.348 1.357 0.001 2
FiO2>0.35 (>4 l/min) 0.904 0.443 1.365 0.000 2
Albumin <3.5 0.792 0.359 1.226 0.000 1.5
SpO2<95% 0.733 0.317 1.148 0.001 1.5
Excluded variables*
Pancreatitis 0.273 −0.866 1.413 0.638 -
Thoracic surgery 1.187 −2.476 4.849 0.525 -
Near drowning
a 14.509 −7692.1 7721.1 0.997 -
Alcohol abuse
a 0.099 −0.618 0.817 0.786 -
Smoking −0.054 −0.504 0.397 0.816 -
Tachypnea 0.074 −0.596 0.745 0.828
*Variables were removed secondary to minimal effect size;
afewer than ten
patients with variable.
Table 1 Comparison of derivation and validation cohorts (Continued)
FiO2>0.35, no. (%) 841 (19.3%) 381 (19.1%) 452 (19.1%) 0.937
Albumin level 3.5 (2.9, 4.0) 3.5 (3.0, 4.0) 3.5 (2.9, 4.0) 0.068
Hypoalbuminemia 945 (47.1%) 414 (45.4%) 531 (48.5%) 0.167
pH median 7.4 (7.3, 7.4) 7.4 (7.3, 7.4) 7.4 (7.3, 7.4) 0.632
Acidosis (pH <7.35) 476 (45.9%) 206 (43.6%) 270 (47.8%) 0.173
Outcome
ALI/ARDS 303 (7.0%) 127 (6.4%) 176 (7.5%) 0.153
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(176/2,361), respectively, p=0.15. There were no statisti-
cally significant differences detected between the deriv-
ation and validation cohorts (Table 1).
Derivation of prediction rule
The weighting of EDLIPS points was adjusted based on
the multivariate logistic regression analysis in the deriv-
ation cohort of 2,000 randomly selected patients and
was validated in the remaining (2,361) patients (Table 2).
Emergency department admissions requiring cardiac,
aortic, or spine surgeries had the highest assignments of
EDLIPS points, conferring the highest associated risk
for ALI development. Other factors were also observed
to have significant effect including the presentation of
acute abdomen, multiple long bone fractures, traumatic
brain injury, aspiration, shock, chemotherapy, acidosis,
or an oxygen requirement of >0.35 FiO2. A modest in-
fluence on progression to ALI was observed with male
gender, pneumonia, sepsis, lung contusion, obesity,
hypoalbuminemia, and hypoxemia. In contrast, the
pre-admission diagnosis of diabetes mellitus conferred
protection from ALI with an assignment of negative 0.5
points. The EDLIPS model calculation worksheet and
examples of how to calculate the score are presented.
(Table 3).
The model was well calibrated in both training and
testing data sets. EDLIPS scores ranged from −0.5 to 15,
median 3.5 (IQR: 2.0, 5.0). Among patients who ultim-
ately developed ALI, the median LIPS score was 6.5
(IQR: 4.5, 8.0) compared to those who did not, median
3.5 (IQR: 2.0, 5.0). Overall, the incidence of ALI
increased with increasing LIPS score. EDLIPS score ≥7
was associated with a 27.9% frequency of ALI develop-
ment, while a score of ≤3 had a frequency of 1.7%. Hos-
pital mortality was 19.2% for those with an LIPS score ≥7
compared to 2.6% for those with a score of ≤3 (Figure 2).
EDLIPS discriminated patients who developed ALI
from those who did not with an AUC of 0.78 (95% CI
0.75, 0.82) (Figure 3). At an EDLIPS cutoff of 5.0 (range
−0.5-15), positive and negative likelihood ratios (95% CI)
for ALI development were 2.74 (2.43, 3.07) and 0.39
(0.30, 0.49), respectively, with a sensitivity of 0.72 (0.64,
0.78), specificity of 0.74 (0.72, 0.746), positive predictive
value of 0.18 (0.15, 0.21), and negative predictive value
of 0.97 (0.96, 0.98) (Table 4).
In contrast, the APACHE II score had limited prog-
nostic accuracy for ALI development of AUC 0.70 (95%
CI 0.66, 0.74),p value <0.001, compared to EDLIPS
(Figure 3).
In-hospital mortality was higher for patients with ALI
compared to those without (27.7% vs 4.6%, p<0.001).
The unadjusted odds ratio of death from ALI/ARDS is
7.90 (95% CI:5.90,10.56),p<0.001. After adjusting for
both EDLIPS and APACHE II scores, the odds ratio for
hospital mortality is 1.29 (95% CI: 1.23, 1.36), p<0.001,
and 1.17 (95%CI: 1.15, 1.19), p<0.001, respectively.
When compared to the performance of the EDLIPS
score, there was no statistically significant difference
from the original LIPS in predicting the cohort of
patients who developed ALI: original LIPS AUC [0.80
(95% CI: 0.76, 0.83) p=0.07].
Table 3 EDLIPS score calculation worksheet
Using Table 2 examples
i. Patient with history of cirrhosis with septic shock from
pneumonia requiring FIO2>0.35 in the emergency room:
Sepsis+shock+pneumonia+cirrhosis+FIO2>0.35
1+2+1+1+2=7
ii. Motor vehicle accident with traumatic brain injury, lung
contusion, and shock requiring FiO2>0.35
Brain injury+lung contusion+shock+FiO2>0.35
2+1+2+2=7
iii. Patient with history of diabetes mellitus presents with
urosepsis, acidosis and shock
Sepsis+shock+acidosis+diabetes
1+2+2–0.5=4.5
In this cohort the lowest and highest EDLIPS scores achieved were −0.5, 15.
Figure 2 Frequency of ALI/ARDS development and hospital mortality according to EDLIPS value (n=4,361).
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Since the 1990s, US hospitals have experienced a 55%
increase in critically ill presentations to EDs. With over
110 million visits a year, the trend in emergency medi-
cine investigations has been directed at early risk stratifi-
cation and goal-directed care, particularly in the
critically ill. Hou et al. report that in the at-risk popula-
tion of ED patients, up to 7% develop ALI within a me-
dian of 2 days (IQR 2–5) [22].
ALI can represent a devastating pulmonary process
associated with increased length of stay, costs, and long-
term poor outcomes [23,24]. Moreover, it represents a
disease that has the potential to impart a burden across
a younger and healthier population than previously
recognized [25]. The median age of this EDLIPS cohort
was 56 years. In one 5-year longitudinal trial, survivors
complained of persistent neuropsychological impairment
and high personal medical expenditures [26]. Persistent
exercise limitation and pulmonary fibrosis are common
[26-28]. Preventing ALI and progression to ARDS has
the potential to facilitate the return of viable at-risk
patients back to their communities with the capacity to
provide meaningful contributions to society.
This preliminary study suggests that the risk of progres-
sion to ALI may be ascertained using the EDLIPS. The
score and consequent degree of risk varies according to
Figure 3 Receiver operating characteristic curves for EDLIPS points, LIPS points, and APACHE II in the validation group (n=2361). AUC
(95% CI) for LIPS: 0.784 (0.748-0.820), AUC (95% CI) for APACHE II: 0.704 (0.663-0.744), P-value<0.001 (Compared to LIPS), AUC (95% CI) Original
LIPS: 0.797 (0.763, 0.831), P-value=0.069 (Compared to LIPS).
Table 4 Sensitivity analysis: EDLIPS performance at different cutoff points (n=2,361)
EDLIPS cutoff points
EDLIPS performance ≥5* ≥4 ≥6
Prevalence of ALI/ARDS (95% CI) 0.075 (0.065, 0.086) 0.075 (0.065, 0.086) 0.075 (0.065, 0.086)
Sensitivity (95% CI) 0.716 (0.643, 0.781) 0.852 (0.791, 0.901) 0.557 (0.480, 0.632)
Specificity (95% CI) 0.738 (0.719, 0.757) 0.592 (0.571, 0.613) 0.848 (0.832, 0.862)
Positive predictive value 0.181 (0.153, 0.211) 0.144 (0.123, 0.167) 0.227 (0.189, 0.270)
Negative predictive value 0.970 (0.961, 0.978) 0.980 (0.971, 0.987) 0.960 (0.950, 0.968)
Likelihood ratio (+)(95% CI) 2.735 (2.434, 3.073) 2.088 (1.928, 2.261) 3.654 (3.099, 4.308)
Likelihood ratio (−)(95% CI) 0.385 (0.304, 0.487) 0.250 (0.175, 0.357) 0.523 (0.443, 0.618)
C-statistic (95% CI) 0.727 (0.692, 0.762) 0.722 (0.694, 0.750) 0.702 (0.748, 0.820)
*Depicts optimal cutoff.
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ing that emergency high-risk surgeries, traumatic injuries,
and shock were strong indicators is consistent with the lit-
erature, which cites a high incidence of ARDS in these
populations [29]. Our model also found that the require-
ment of >4 l/min and chemotherapy was a determinate in
progression to ALI, similar to previously published work
by Levitt et al. [30].
Other predisposing conditions analyzed, such as near
drowning, may have also proven to be strong predictors;
however, there were too few cases to reliably detect an
effect. It remains unclear, however, why the existence of
diabetes mellitus confers protection to patients. Previous
investigations have noted a lower incidence of ALI
among diabetics compared to their non-diabetic cohorts.
Honiden and Gong suggest that hyperglycemia as well
as the therapeutic interaction of medications may alter
the inflammatory response associated with ALI/ARDS
development [21].
It is interesting that conditions such as pneumonia
and pancreatitis were not stronger predictors in this
cohort. The study was not designed to assess the
severity of illness. The high number of patients present-
ing with less complicated disease may have dampened
any resulting signal from severe cases of pneumonia or
acute pancreatitis. However, the concomitant existence
of hypoxemia, high oxygen requirement, and/or acidosis,
for example, would increase a patient’s risk for develop-
ing ALI.
When compared to the previously published scoring
methodology of LIPS, the EDLIPS affords a number of
advantages. It identifies patients who are at risk for ALI
from a broader scale of potential presenting symptoms
and predisposing conditions in the ED. While EDLIPS
did not out-perform original LIPS, its ability to discrim-
inate patients who would go on to develop ALI is com-
parable in this study. Moreover, EDLIPS is derived from
a targeted population of ED patients and lacks the het-
erogeneity included in the original LIPS cohort of
patients admitted from the ED and patients undergoing
high-risk elective surgeries.
This affords the potential for EDLIPS to discern fac-
tors unique to the ED population. It is notable that in
one 8-year longitudinal study of ARDS, the hospital and
ICU populations experienced a dramatic reduction in
ARDS attributed to clinical interventions, while the inci-
dence of early onset ARDS within 6 h of ED admission
remained unchanged [31]. This suggests potential differ-
ences in the mechanistic pathways in the development
of ALI.
This EDLIPS scoring method is designed for the ED
setting utilizing routinely available clinical variables that
can readily be identified upon presentation for risk
stratification predicting progression to ALI and in-
patient mortality. Moreover, the scoring system has the
potential to allow for the investigation of preventive
measures in the emergency department. While the
authors acknowledge APACHE II was not designed or
intended to predict ALI, it is a broadly recognized as-
sessment tool utilized among critically ill patients. APA-
CHE II is consistently referenced as the model when
validating the performance of customized scores in a
heterogeneous population of critically ill patients. As
such, it is not surprising that it lacks discriminating cap-
acity in predicting ALI when compared to EDLIPS.
However, it is notable that EDLIPS with increasing
scores predicted an increasing trend of mortality, sug-
gesting an increased severity of illness, for which pur-
pose the APACHE had been originally designed.
Moreover, from the standpoint of clinical practice, when
compared to EDLIPS, APACHE II requires 12 separate
physiological data points and a sophisticated calculation
scheme to derive a score over a 24-h period. Its use in
the ED is not feasible [32,33].
A frequent consequence of critical illness in the emer-
gency department is intubation and mechanical ventila-
tion, a hallmark of ED resuscitation and a requisite
component of the clinical management of the ALI/
ARDS patient. Studies suggest that early ventilator set-
tings influence downstream outcome of critically ill
patients [34]. The application of mechanical ventilation
can induce pulmonary damage by means of a process
termed ventilator-associated lung injury (VALI). Both
animal and human studies demonstrate upregulation of
inflammatory cytokines, which compromise the alveolar
capillary membrane when increased volumes are applied
to the lung parenchyma. This mechanical stress can pro-
duce a stimulus that induces the transformation of a
normal lung to a lung with histological appearance in-
distinguishable from ALI induced by sepsis, shock, or
pneumonia [35-38]. The clinical impact of high tidal vol-
ume ventilation was underscored by the Acute Respira-
tory Distress Syndrome Network study. Utilizing the
lower tidal volume, mortality from ARDS was reduced
from 39.8% to 31% [15]. To date, the primary strategy
proven to be effective at reducing mortality from ALI is
low tidal volume ventilation by targeting a reduction in
VALI. Even more compelling is an investigation by
Determann et al. demonstrating that randomly selected
patients without ALI placed on mechanical ventilation
with low tidal volumes of 6 ml/kg were less likely to de-
velop ALI than those placed on 10 ml/kg predicted body
weight (2.6%, 13.5%, p=0.01 [39]).
Assuming preventive strategies are identified, the
EDLIPS has the potential to result in substantial morbid-
ity and mortality reduction as well as cost savings. Spe-
cifically, an EDLIPS of ≥5 should prompt the clinician
team to closely monitor the patient and communicate
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tory status to the receiving service; this in turn would
allow for the institution of preventive measures.
The transition of ALI studies from the ICU to the ED
population may not only be prudent but obligatory as
studies demonstrate the preponderance of ARDS cases
are likely to stem from ED admissions secondary to
insults exposed in the community. Hence, investigations
evaluating the use of antiplatelet and statin therapies, a
low tidal volume ventilation strategy, and restrictive
transfusion in the ED may indeed be needed to mitigate
ALI development [40-43]. Designed as a bundle, these
interventions have the potential to curb the progression
of illness in a patient identified at risk when instituted
early.
Limitations
While the EDLIPS model did accurately identify most
ALI patients at higher LIPS scores, it is notable that the
model has a modest AUC. So, while a robust negative
predictive value of 0.97 renders the model useful in
screening patients with low risk for ALI, the weaker
positive predictive value does lack precision in identify-
ing those at high risk for ALI. Alternatively, the use of a
higher threshold score may enhance the model’s per-
formance in the clinical setting.
Future directions
This study represents an initial attempt to refine a scor-
ing methodology of emergency department patients for
the purpose of predicting ALI development. External
validation will be necessary to determine whether
EDLIPS can be generalized to clinical practice. More-
over, it is unclear what specific impact the implementa-
tion of this scoring system will have on physician
practice, patient outcomes, or resource utilization. Fur-
ther studies will be needed to assess the application of
this scoring system in conjunction with outlined strat-
egies known to have an impact on clinical parameters in
patients at risk for ALI.
Conclusions
In this study, we describe a variation on a novel scoring
method that screens and stratifies patients at greatest
risk for developing ALI in the ED. Although the overall
performance is modest, an excellent negative predictive
value makes it a useful screening tool. EDLIPS perform-
ance was similar to the original LIPS model and signifi-
cantly better than APACHE II in predicting ALI
development. Confirmation of these results in other ED
populations and the identification of additional risk fac-
tors could aid both the identification of susceptible indi-
viduals and the targeting of therapies.
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